An Open-Label Study of Apabetalone in Covid Infection
Status:
Recruiting
Trial end date:
2022-09-22
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety and effect on clinical course of
oral apabetalone in hospitalized subjects with Covid-19 infection